AU2010201022B2 — Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
Assigned to Teva Womens Health Inc · Expires 2012-09-27 · 14y expired
What this patent protects
C:\NRPotnbDCC\KXGU77549Q_. DOC-17/03/2OIO The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be admin…
USPTO Abstract
C:\NRPotnbDCC\KXGU77549Q_. DOC-17/03/2OIO The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits. Cj) coJ - -o SIUGI~d 10
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.